Fortress Biotech, Inc. (FBIO)
2.35
-0.16
(-6.37%)
USD |
NASDAQ |
Apr 07, 16:00
2.335
-0.02
(-0.64%)
After-Hours: 20:00
Fortress Biotech Shareholders Equity (Quarterly) : 49.87M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Journey Medical Corp. | 31.85M |
| Vertex Pharmaceuticals, Inc. | 18.67B |
| Oramed Pharmaceuticals, Inc. | 199.74M |
| Avenue Therapeutics, Inc. | 1.832M |
| Lyell Immunopharma, Inc. | 248.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 185.55M |
| Total Liabilities (Quarterly) | 123.36M |
| Debt to Equity Ratio | 1.348 |
| Current Ratio | 2.490 |
| Net Debt Paydown Yield | 0.75% |